The first,
coagulation factor VIII, is critical to hemophilia therapies.
Clinical evaluation of viral safety of
coagulation factor VIII and IX concentrates.
Lupus anticoagulants and their relationship with the inhibitors against
coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants.
Hemophilia is an X-linked hereditary bleeding disorder, characterized by impaired blood coagulation as a result of deficiencies in the production or function of
coagulation factor VIII (hemophilia A) or factor IX (hemophilia B).
Traditional blood bank preparations of Cryo contain high concentrations of antihemophilic factor (plasma
coagulation factor VIII) and fibrinogen, but require several days, numerous pieces of laboratory equipment, and considerable staff handling to prepare [1].
Biopharmaceutical company Baxalta (NYSE:BXLT) reported on Thursday the receipt of approval for Health Canada's OBIZUR for the treatment of bleeding episodes in patients with acquired hemophilia A caused by autoantibodies to
coagulation Factor VIII (FVIII).